TŐkÉs T - Search Results

1

Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients.

TŐkÉs T, Dank M, Lengyel Z, Kajáry K. TŐkÉs T, et al. Q J Nucl Med Mol Imaging. 2020 Dec;64(4):406-413. doi: 10.23736/S1824-4785.19.03114-5. Epub 2019 Feb 21. Q J Nucl Med Mol Imaging. 2020. PMID: 30792380

2

[The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission].

Tőkés T, Somlai K, Székely B, Kulka J, Szentmártoni G, Torgyík L, Galgóczy H, Lengyel Z, Györke T, Dank M. Tőkés T, et al. Orv Hetil. 2012 Dec 9;153(49):1958-64. doi: 10.1556/OH.2012.29495. Orv Hetil. 2012. PMID: 23204302 Hungarian.

3

Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.

Kajáry K, Tőkés T, Dank M, Kulka J, Szakáll S Jr, Lengyel Z. Kajáry K, et al. Among authors: tokes t. Nucl Med Commun. 2015 Jan;36(1):28-37. doi: 10.1097/MNM.0000000000000217. Nucl Med Commun. 2015. PMID: 25299471

4

Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study.

Tőkés T, Szentmártoni G, Torgyík L, Kajáry K, Lengyel Z, Györke T, Molnár BÁ, Tőkés AM, Kulka J, Dank M. Tőkés T, et al. Among authors: tokes am. Croat Med J. 2015 Apr;56(2):128-38. doi: 10.3325/cmj.2015.56.128. Croat Med J. 2015. PMID: 25891872 Free PMC article.

5

Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer.

Tőkés T, Kajáry K, Szentmártoni G, Lengyel Z, Györke T, Torgyík L, Somlai K, Tőkés AM, Kulka J, Dank M. Tőkés T, et al. Among authors: tokes am. Breast Cancer. 2017 Jan;24(1):137-146. doi: 10.1007/s12282-016-0685-4. Epub 2016 Mar 15. Breast Cancer. 2017. PMID: 26979062

6

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations.

Kajáry K, Lengyel Z, Tőkés AM, Kulka J, Dank M, Tőkés T. Kajáry K, et al. Among authors: tokes t. Pathol Oncol Res. 2020 Apr;26(2):997-1006. doi: 10.1007/s12253-019-00641-0. Epub 2019 Apr 3. Pathol Oncol Res. 2020. PMID: 30941738 Free PMC article.

7

[Monoclonal antibody therapy in breast cancer].

Dank M, Tõkés T. Dank M, et al. Among authors: tokes t. Magy Onkol. 2013 Sep;57(3):157-65. Epub 2013 Aug 9. Magy Onkol. 2013. PMID: 24107821 Free article. Review. Hungarian.

8

Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond-Preliminary Results.

Tőkés T, Szentmártoni G, Torgyík L, Somlai K, Kulka J, Lengyel Z, Györke T, Dank M. Tőkés T, et al. Anticancer Res. 2015 Sep;35(9):5063-72. Anticancer Res. 2015. PMID: 26254408

9

Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future?

Tőkés T, Torgyík L, Szentmártoni G, Somlai K, Tóth A, Kulka J, Dank M. Tőkés T, et al. Patient Educ Couns. 2015 Jun;98(6):695-703. doi: 10.1016/j.pec.2015.02.012. Epub 2015 Feb 25. Patient Educ Couns. 2015. PMID: 25749023 Review.

10

Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.

Tőkés T, Tőkés AM, Szentmártoni G, Kiszner G, Madaras L, Kulka J, Krenács T, Dank M. Tőkés T, et al. Among authors: tokes am. Virchows Arch. 2016 Jun;468(6):675-86. doi: 10.1007/s00428-016-1925-x. Epub 2016 Mar 30. Virchows Arch. 2016. PMID: 27026269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters